Victory Capital Management’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,156
| Closed | -$109K | – | 2478 |
|
|
2024
Q4 | $109K | Sell |
10,156
-269
| -3% | -$2.89K | ﹤0.01% | 2330 |
|
|
2024
Q3 | $59.2K | Sell |
10,425
-172
| -2% | -$977 | ﹤0.01% | 2377 |
|
|
2024
Q2 | $44.7K | Buy |
10,597
+127
| +1% | +$536 | ﹤0.01% | 2381 |
|
|
2024
Q1 | $53.3K | Sell |
10,470
-247
| -2% | -$1.26K | ﹤0.01% | 2371 |
|
|
2023
Q4 | $99.8K | Buy |
+10,717
| New | +$99.8K | ﹤0.01% | 2344 |
|
|
2022
Q3 | – | Sell |
-17,097
| Closed | -$171K | – | 2707 |
|
|
2022
Q2 | $171K | Sell |
17,097
-10,900
| -39% | -$109K | ﹤0.01% | 2382 |
|
|
2022
Q1 | $240K | Buy |
27,997
+5,404
| +24% | +$46.3K | ﹤0.01% | 2366 |
|
|
2021
Q4 | $392K | Buy |
22,593
+10,783
| +91% | +$187K | ﹤0.01% | 2289 |
|
|
2021
Q3 | $212K | Buy |
+11,810
| New | +$212K | ﹤0.01% | 2505 |
|